— Know what they know.
Not Investment Advice
Also trades as: HUMAW (NASDAQ) · $vol 0M

HUMA NASDAQ

Humacyte, Inc.
1W: +2.0% 1M: +44.7% 3M: -9.7% YTD: +4.6% 1Y: -59.0% 3Y: -73.8% 5Y: -89.7%
$1.05
+0.03 (+2.94%)
 
Weekly Expected Move ±19.4%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 62 · $176.4M mcap · 138M float · 5.04% daily turnover · Short 65% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
34.0 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -515.4%
Cost Advantage
34
Intangibles
34
Switching Cost
38
Network Effect
39
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. HUMA has No discernible competitive edge (34.0/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. Negative ROIC of -515.4% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$4
Avg Target
$4
High
Based on 3 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$4.17
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2025-12-01 H.C. Wainwright Swayampakula Ramakanth Initiated $3 +122.2% $1.35
2025-10-13 UBS Initiated $6 +256.9% $1.68
2025-08-27 Barclays Matt Miksic Initiated $4 +138.1% $1.47
2024-10-18 Piper Sandler Matt O'Brien $4 $6 +2 +23.5% $4.86
2024-10-18 BTIG Ryan Zimmerman Initiated $10 +105.8% $4.86
2022-12-20 Cowen & Co. Cowen Cowen Initiated $5 +126.5% $2.21
2022-05-15 Piper Sandler Matt O'Brien Initiated $4 -25.5% $5.37

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. HUMA receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-03-30 C- D+
2026-03-27 C+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

3 Grade D
Profitability
0
Balance Sheet
31
Earnings Quality
54
Growth
12
Value
23
Momentum
20
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. HUMA scores highest in Earnings Quality (54/100) and lowest in Profitability (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-10.70
Distress Zone
Piotroski F-Score
1/9
Beneish M-Score
-2.87
Unlikely Manipulator
Ohlson O-Score
0.38
Bankruptcy prob: 59.3%
High Risk
Credit Rating
B-
Score: 21.9/100
Trend: Improving
Earnings Quality
OCF/NI: 1.04x
Accruals: 3.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. HUMA scores -10.70, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. HUMA scores 1/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. HUMA's score of -2.87 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. HUMA's implied 59.3% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. HUMA receives an estimated rating of B- (score: 21.9/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-2.13x
PEG
0.01x
P/S
87.50x
P/B
17.87x
P/FCF
-1.17x
P/OCF
EV/EBITDA
-1.31x
EV/Revenue
66.66x
EV/EBIT
-1.22x
EV/FCF
-1.31x
Earnings Yield
-81.30%
FCF Yield
-85.29%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. HUMA currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.889
EBT / EBIT
×
EBIT Margin
-54.455
EBIT / Rev
×
Asset Turnover
0.016
Rev / Assets
×
Equity Multiplier
-5.130
Assets / Equity
=
ROE
393.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. HUMA's ROE of 393.8% is driven by Asset Turnover (0.016), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1375 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1.05
Median 1Y
$0.46
5th Pctile
$0.10
95th Pctile
$2.09
Ann. Volatility
92.4%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Laura E. Niklason
President and Chief Executive Officer
$633,606 $— $5,234,908
Dale A. Sander
Chief Financial Officer, Chief Corporate Development Officer and Treasurer
$545,968 $382,653 $2,131,658
Shamik J. Parikh
Chief Medical Officer
$519,499 $382,653 $2,096,556

CEO Pay Ratio

31:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $5,234,908
Avg Employee Cost (SGA/emp): $169,408
Employees: 184

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
184
-16.4% YoY
Revenue / Employee
$11,076
Rev: $2,038,000
Profit / Employee
$-221,918
NI: $-40,833,000
SGA / Employee
$169,408
Avg labor cost proxy
R&D / Employee
$376,641
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -76.0% -1.2% -27.5% -27.0% 29.1% 35.6% -10.0% -24.3% -74.2% -74.8% -1.7% -1.6% -2.1% -2.3% 7.6% 4.0% 3.0% 1.9% 1.6% 3.9% 3.94%
ROA -50.3% -79.9% -13.5% -13.2% 14.3% 17.5% -4.9% -11.9% -36.1% -36.4% -66.6% -63.6% -84.0% -91.9% -1.1% -58.4% -44.1% -27.8% -32.1% -76.8% -76.77%
ROIC -72.5% -99.7% 1.2% 1.3% 1.6% 1.6% -4.4% -4.5% -4.9% -4.9% 8.4% 8.7% 8.9% 9.4% 1.1% 1.1% 1.1% 1.0% -4.9% -5.2% -5.15%
ROCE -57.3% -78.8% -29.5% -29.0% -28.7% -29.8% -44.0% -53.2% -55.9% -56.4% -97.3% -92.6% -1.2% -1.3% -1.2% -57.0% -40.9% -22.3% -39.5% -1.1% -1.12%
Gross Margin -20.1% -62.8% -90.8% -7.8% -10.3% -65.0% 50.0% -2.8% -5.9% 65.5% -22.3% -3.1% -3.12%
Operating Margin -27.9% -85.2% -122.2% -93.4% -14.2% -757.9% -3.9% -44.8% -98.8% -32.4% -66.0% -58.5% -58.45%
Net Margin -24.9% -131.0% 240.6% -85.1% 28.3% -815.5% -2.9% 75.7% -125.1% -23.3% -53.1% -35.6% -35.59%
EBITDA Margin -24.9% -76.7% -110.6% -70.2% -12.7% -696.5% -2.3% 85.1% -110.5% -17.3% -62.2% -54.8% -54.84%
FCF Margin -45.9% -85.8% -87.2% -85.3% -59.6% -42.5% -46.1% -54.9% -2565.7% -13.8% -13.0% -13.2% -12.1% -52.0% -50.8% -50.78%
OCF Margin -45.8% -85.6% -86.9% -85.0% -59.4% -42.3% -45.4% -53.3% -2484.1% -13.6% -12.8% -13.0% -12.0% -51.5% -50.4% -50.37%
ROA 3Y Avg snapshot only -74.21%
ROIC Economic snapshot only -1.32%
Cash ROA snapshot only -87.26%
Cash ROIC snapshot only -5.82%
CROIC snapshot only -5.86%
NOPAT Margin snapshot only -44.63%
Pretax Margin snapshot only -48.41%
R&D / Revenue snapshot only 36.38%
SGA / Revenue snapshot only 14.47%
SBC / Revenue snapshot only 2.45%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -19.54 -5.98 -28.68 -27.96 11.89 9.78 -18.19 -10.96 -3.33 -3.39 -2.66 -3.18 -4.10 -4.25 -4.02 -2.90 -5.54 -7.45 -3.72 -1.23 -2.129
P/S Ratio 1083.18 421.71 601.26 542.29 170.87 192.82 139.09 239.55 9535.93 82.78 29.09 40.38 31.31 74.54 59.54 87.500
P/B Ratio 14.85 7.22 6.22 5.95 2.73 2.75 1.86 2.73 2.53 2.59 21.72 24.85 42.23 47.95 -11.36 -4.28 -6.17 -5.23 48.86 38.61 17.872
P/FCF -23.57 -4.91 -6.90 -6.36 -2.87 -4.54 -3.02 -4.36 -3.72 -3.99 -3.89 -4.03 -6.98 -7.04 -6.00 -2.24 -3.06 -2.59 -1.43 -1.17 -1.172
P/OCF
EV/EBITDA -21.19 -7.40 -7.96 -7.72 -2.24 -2.18 -1.58 -2.41 -2.04 -2.08 -2.77 -3.37 -4.43 -4.62 -4.31 -3.29 -7.26 -13.05 -5.30 -1.31 -1.311
EV/Revenue 1071.76 412.56 463.24 412.29 81.57 92.74 74.03 163.12 6251.64 78.85 25.42 36.85 28.08 81.58 66.66 66.658
EV/EBIT -18.98 -6.63 -7.20 -6.92 -2.01 -1.97 -1.42 -2.21 -1.88 -1.93 -2.54 -3.09 -4.16 -4.34 -4.09 -2.93 -6.15 -9.39 -4.30 -1.22 -1.224
EV/FCF -23.33 -4.81 -5.31 -4.83 -1.37 -2.18 -1.61 -2.97 -2.44 -2.65 -3.59 -3.75 -6.70 -6.79 -5.72 -1.95 -2.79 -2.32 -1.57 -1.31 -1.313
Earnings Yield -5.1% -16.7% -3.5% -3.6% 8.4% 10.2% -5.5% -9.1% -30.0% -29.5% -37.6% -31.4% -24.4% -23.5% -24.9% -34.5% -18.1% -13.4% -26.9% -81.3% -81.30%
FCF Yield -4.2% -20.3% -14.5% -15.7% -34.9% -22.0% -33.2% -22.9% -26.9% -25.1% -25.7% -24.8% -14.3% -14.2% -16.7% -44.7% -32.7% -38.6% -69.7% -85.3% -85.29%
PEG Ratio snapshot only 0.009
Price/Tangible Book snapshot only 38.608
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 3.69 3.69 20.75 20.75 20.75 20.75 7.88 7.88 7.88 7.88 4.52 4.52 4.52 4.52 2.40 2.40 2.40 2.40 3.69 3.69 3.690
Quick Ratio 3.69 3.69 20.75 20.75 20.75 20.75 7.88 7.88 7.88 7.88 4.52 4.52 4.52 4.52 2.40 2.40 2.40 2.40 2.95 2.95 2.950
Debt/Equity 0.41 0.41 0.42 0.42 0.42 0.42 0.43 0.43 0.43 0.43 4.24 4.24 4.24 4.24 -0.31 -0.31 -0.31 -0.31 20.86 20.86 20.858
Net Debt/Equity -0.16 -0.16 -1.43 -1.43 -1.43 -1.43 -0.87 -0.87 -0.87 -0.87 -1.70 -1.70 -1.70 -1.70 4.62 4.62 4.615
Debt/Assets 0.27 0.27 0.18 0.18 0.18 0.18 0.25 0.25 0.25 0.25 0.45 0.45 0.45 0.45 0.12 0.12 0.12 0.12 0.56 0.56 0.557
Debt/EBITDA -0.59 -0.43 -0.70 -0.71 -0.72 -0.69 -0.68 -0.56 -0.53 -0.52 -0.59 -0.62 -0.46 -0.42 -0.13 -0.28 -0.40 -0.87 -2.07 -0.63 -0.633
Net Debt/EBITDA 0.23 0.16 2.37 2.43 2.46 2.35 1.39 1.13 1.07 1.05 0.23 0.25 0.19 0.17 0.21 0.47 0.70 1.50 -0.46 -0.14 -0.140
Interest Coverage -23.90 -21.54 -18.68 -15.22 -14.33 -13.80 -13.12 -15.19 -15.45 -16.01 -16.19 -15.13 -17.57 -16.99 -15.03 -6.42 -4.59 -2.47 -3.44 -10.43 -10.435
Equity Multiplier 1.51 1.51 2.35 2.35 2.35 2.35 1.75 1.75 1.75 1.75 9.47 9.47 9.47 9.47 -2.62 -2.62 -2.62 -2.62 37.43 37.43 37.429
Cash Ratio snapshot only 2.749
Debt Service Coverage snapshot only -9.740
Cash to Debt snapshot only 0.779
FCF to Debt snapshot only -1.579
Defensive Interval snapshot only 184.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.06 0.06 0.07 0.02 0.02 0.016
Inventory Turnover 2.23 2.24 2.243
Receivables Turnover 8.58 10.71 8.74 9.28 13.51 12.06 15.12 12.87 0.30 0.00 0.00 0.00 0.00 0.00 9.24 9.14 9.143
Payables Turnover 12.89 19.66 21.87 22.09 22.13 16.03 18.27 17.16 20.35 19.96 6.24 6.68 2.05 2.18 1.65 1.68 1.73 1.44 3.07 3.08 3.081
DSO 43 34 42 39 27 30 24 28 1219 0 0 0 0 39 40 39.9 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 163 163 162.7 days
DPO 28 19 17 17 16 23 20 21 18 18 58 55 178 168 222 217 211 253 119 118 118.5 days
Cash Conversion Cycle 14 16 25 23 11 8 4 7 1201 -222 -217 -211 -253 84 84 84.2 days
Fixed Asset Turnover snapshot only 0.042
Operating Cycle snapshot only 202.6 days
Cash Velocity snapshot only 0.040
Capital Intensity snapshot only 57.721
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 9.2% 3.8% 1.0% 44.0% 23.9% -0.7% -98.4% -1.0% -1.0% -1.0% -1.0% -71.8% -74.0% -73.97%
Net Income -63.3% 28.8% 1.5% 1.4% 54.8% -11.9% -4.2% -3.6% -8.3% -2.6% -57.5% -71.0% -34.2% 26.5% 58.0% 75.8% 72.5% -25.7% -25.65%
EPS 95.5% 28.8% 1.5% 1.2% 54.1% -11.6% -4.2% -3.6% -8.2% -2.5% -36.6% -48.1% -17.4% 39.6% 67.8% 81.8% 79.4% 16.3% 16.32%
FCF -6.2% -2.8% -1.6% 28.7% 34.4% 36.0% 31.6% -2.7% -4.7% -14.2% -3.0% -21.4% -31.9% -20.7% -29.8% -15.3% -6.3% -1.6% -1.58%
EBITDA -4.4% -1.3% -44.7% -9.7% 0.5% -25.6% -34.1% -30.7% -34.1% -3.5% -30.2% -40.1% -34.8% 35.7% 67.0% 86.0% 76.3% -71.0% -71.00%
Op. Income -4.2% -1.3% -50.7% -13.5% -4.1% -2.6% -13.4% -10.8% -18.3% -22.0% -14.3% -18.8% -14.3% -6.6% -4.1% 6.3% 5.5% -2.6% -2.60%
OCF Growth snapshot only -2.18%
Asset Growth snapshot only -15.60%
Debt Growth snapshot only 2.92%
Shares Change snapshot only 50.16%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 78.9% 79.4% 60.3% 71.6% 9.2% 14.8% 14.81%
Revenue 5Y 75.0% 48.5% 48.52%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 6.3% 6.3% 6.3% 6.3% -21.6% -21.6% -21.6% -21.6% -17.1% -17.1% -17.11%
Assets 5Y 1.8% 1.8% 1.75%
Equity 3Y -42.3% -42.3% -42.3% -42.3% -70.2% -70.2% -70.15%
Book Value 3Y -82.5% -43.3% -45.1% -58.7% -74.1% -76.0% -75.97%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.90 0.74 0.24 0.46 0.00 0.02 0.45 0.62 0.43 0.44 0.38 0.43 0.26 0.24 0.238
Earnings Stability 0.08 0.47 0.09 0.00 0.55 0.52 0.47 0.29 0.77 0.53 0.21 0.04 0.31 0.64 0.639
Margin Stability 0.17 0.60 0.00 0.17 0.60 0.00 0.05 0.09 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.95 0.20 0.20 0.50 0.50 0.50 0.50 0.86 0.89 0.50 0.50 0.50 0.90 0.897
Earnings Smoothness
ROE Trend 0.12 0.12 -0.49 -0.30 -8.02 -7.57 -10.05 -11.04
Gross Margin Trend 50.59 20.67 -1183.58
FCF Margin Trend 58.79 41.09 -2512.91
Sustainable Growth Rate 29.1% 35.6%
Internal Growth Rate 16.6% 21.2%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.83 1.21 4.15 4.39 -4.13 -2.14 5.94 2.44 0.87 0.82 0.66 0.78 0.58 0.59 0.66 1.28 1.78 2.85 2.57 1.04 1.041
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.03 1.03 1.04 1.03 1.02 1.02 1.02 1.02 1.01 1.02 1.01 1.01 1.01 1.008
FCF/Net Income snapshot only 1.049
CapEx/Revenue 10.8% 23.1% 24.7% 22.7% 19.3% 23.7% 67.0% 1.6% 81.6% 21.7% 18.2% 22.3% 10.3% 43.4% 41.2% 41.22%
CapEx/Depreciation snapshot only 0.114
Accruals Ratio -0.09 0.17 0.42 0.45 0.73 0.55 0.24 0.17 -0.05 -0.07 -0.23 -0.14 -0.35 -0.37 -0.38 0.16 0.34 0.52 0.51 0.03 0.031
Sloan Accruals snapshot only 0.112
Cash Flow Adequacy snapshot only -122.196
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0%
FCF Payout Ratio
Total Payout Ratio 0.0% 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.0% -0.2% -0.1% -0.1% -0.2% -0.1% -0.1% -0.1% -0.1% -0.1% -0.2% -13.0% -7.8% -7.0% -7.8% -22.3% -16.2% -22.3% -76.8% -77.4% -77.43%
Total Shareholder Return -0.0% -0.2% -0.1% -0.1% -0.2% -0.1% -0.1% -0.1% -0.1% -0.1% -0.2% -13.0% -7.8% -7.0% -7.8% -22.3% -16.2% -22.3% -76.8% -77.4% -77.43%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.98 1.13 0.33 0.33 -0.35 -0.42 0.15 0.30 0.86 0.86 1.04 1.04 1.06 1.06 1.07 1.16 1.22 1.41 1.05 0.89 0.889
EBIT Margin -56.46 -62.19 -64.30 -59.54 -40.52 -47.19 -51.99 -73.75 -3333.03 -19.29 -8.68 -5.99 -2.99 -18.99 -54.46 -54.455
Asset Turnover 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.06 0.06 0.07 0.02 0.02 0.016
Equity Multiplier 1.51 1.51 2.04 2.04 2.04 2.04 2.05 2.05 2.05 2.05 2.55 2.55 2.55 2.55 -6.80 -6.80 -6.80 -6.80 -5.13 -5.13 -5.130
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.52 $-1.94 $-0.25 $-0.25 $0.27 $0.33 $-0.12 $-0.28 $-0.86 $-0.86 $-1.07 $-0.98 $-1.17 $-1.28 $-1.26 $-0.59 $-0.38 $-0.23 $-0.26 $-0.49 $-0.49
Book Value/Share $0.69 $1.61 $1.17 $1.19 $1.18 $1.19 $1.13 $1.13 $1.13 $1.13 $0.13 $0.13 $0.11 $0.11 $-0.44 $-0.40 $-0.34 $-0.33 $0.02 $0.02 $0.06
Tangible Book/Share $0.69 $1.61 $1.17 $1.19 $1.18 $1.19 $1.13 $1.13 $1.13 $1.13 $0.13 $0.13 $0.11 $0.11 $-0.44 $-0.40 $-0.34 $-0.33 $0.02 $0.02 $0.02
Revenue/Share $0.01 $0.03 $0.01 $0.01 $0.02 $0.02 $0.02 $0.01 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.06 $0.06 $0.05 $0.06 $0.01 $0.01 $0.01
FCF/Share $-0.43 $-2.36 $-1.05 $-1.11 $-1.12 $-0.72 $-0.70 $-0.71 $-0.77 $-0.73 $-0.73 $-0.77 $-0.69 $-0.77 $-0.84 $-0.76 $-0.68 $-0.67 $-0.67 $-0.52 $-0.52
OCF/Share $-0.43 $-2.36 $-1.05 $-1.11 $-1.12 $-0.71 $-0.69 $-0.69 $-0.75 $-0.71 $-0.71 $-0.76 $-0.68 $-0.76 $-0.83 $-0.75 $-0.67 $-0.67 $-0.66 $-0.51 $-0.51
Cash/Share $0.39 $0.91 $2.15 $2.19 $2.17 $2.19 $1.47 $1.47 $1.47 $1.47 $0.78 $0.74 $0.68 $0.67 $0.38 $0.34 $0.29 $0.28 $0.32 $0.26 $0.25
EBITDA/Share $-0.48 $-1.54 $-0.70 $-0.70 $-0.68 $-0.72 $-0.71 $-0.87 $-0.92 $-0.94 $-0.95 $-0.86 $-1.04 $-1.14 $-1.12 $-0.45 $-0.26 $-0.12 $-0.20 $-0.52 $-0.52
Debt/Share $0.28 $0.66 $0.49 $0.50 $0.49 $0.50 $0.49 $0.48 $0.48 $0.48 $0.55 $0.53 $0.48 $0.48 $0.14 $0.13 $0.11 $0.10 $0.41 $0.33 $0.33
Net Debt/Share $-0.11 $-0.25 $-1.66 $-1.69 $-1.68 $-1.69 $-0.99 $-0.99 $-0.99 $-0.98 $-0.22 $-0.21 $-0.19 $-0.19 $-0.24 $-0.22 $-0.18 $-0.18 $0.09 $0.07 $0.07
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -10.695
Altman Z-Prime snapshot only -22.803
Piotroski F-Score 2 1 5 5 6 4 3 1 2 1 1 1 1 1 3 3 3 3 2 1 1
Beneish M-Score -0.45 -0.23 1.30 8.06 -2.96 -2.87 -2.867
Ohlson O-Score snapshot only 0.376
ROIC (Greenblatt) snapshot only -1.13%
Net-Net WC snapshot only $-0.23
EVA snapshot only $-91717320.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B-
Credit Score 59.59 39.30 34.24 35.44 29.99 30.40 31.92 31.54 31.37 31.65 23.82 23.96 23.70 23.71 20.00 20.00 20.00 20.00 21.94 21.89 21.892
Credit Grade snapshot only 16
Credit Trend snapshot only 1.892
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 9
Sector Credit Rank snapshot only 10

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms